全文获取类型
收费全文 | 13864篇 |
免费 | 908篇 |
国内免费 | 34篇 |
专业分类
耳鼻咽喉 | 60篇 |
儿科学 | 474篇 |
妇产科学 | 446篇 |
基础医学 | 1940篇 |
口腔科学 | 136篇 |
临床医学 | 1810篇 |
内科学 | 2594篇 |
皮肤病学 | 193篇 |
神经病学 | 1680篇 |
特种医学 | 296篇 |
外科学 | 1348篇 |
综合类 | 111篇 |
一般理论 | 19篇 |
预防医学 | 1477篇 |
眼科学 | 239篇 |
药学 | 961篇 |
中国医学 | 24篇 |
肿瘤学 | 998篇 |
出版年
2024年 | 21篇 |
2023年 | 132篇 |
2022年 | 183篇 |
2021年 | 429篇 |
2020年 | 222篇 |
2019年 | 376篇 |
2018年 | 397篇 |
2017年 | 283篇 |
2016年 | 287篇 |
2015年 | 349篇 |
2014年 | 466篇 |
2013年 | 730篇 |
2012年 | 1081篇 |
2011年 | 1051篇 |
2010年 | 529篇 |
2009年 | 520篇 |
2008年 | 858篇 |
2007年 | 903篇 |
2006年 | 829篇 |
2005年 | 825篇 |
2004年 | 769篇 |
2003年 | 699篇 |
2002年 | 663篇 |
2001年 | 148篇 |
2000年 | 102篇 |
1999年 | 165篇 |
1998年 | 160篇 |
1997年 | 138篇 |
1996年 | 109篇 |
1995年 | 92篇 |
1994年 | 86篇 |
1993年 | 84篇 |
1992年 | 80篇 |
1991年 | 98篇 |
1990年 | 75篇 |
1989年 | 78篇 |
1988年 | 76篇 |
1987年 | 55篇 |
1986年 | 63篇 |
1985年 | 55篇 |
1984年 | 64篇 |
1983年 | 61篇 |
1982年 | 65篇 |
1981年 | 56篇 |
1980年 | 43篇 |
1979年 | 37篇 |
1978年 | 22篇 |
1976年 | 20篇 |
1974年 | 30篇 |
1973年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
Fluid role boundaries: exploring the contribution of the advanced nurse practitioner to multi‐professional palliative care 下载免费PDF全文
5.
6.
Rènée du Toit Katherine Soong Garry Brian Jacqueline Ramke 《Optometry and vision science》2006,83(8):582-588
PURPOSE: The advantages of a focometer (FOCOMETER) over other methods of refraction for use in developing countries are that it is lightweight, compact, relatively inexpensive, fairly quick, and easy to use with minimal training. This clinical trial compared the repeatability, validity, and ease of use of the focometer with an autorefractor. METHODS: The refractive status of the right eye of 80 participants was determined with an autorefractor (Canon RK3). Three measurements were also taken with the focometer. RESULTS: The spherical equivalent (M) of the focometer was 0.25 D more positive than the autorefractor (p < 0.001) and 84% of measurements were within 0.75 D of the autorefractor. The autorefractor detected astigmatism in 91% (73) of the eyes, whereas the focometer identified only 32% (26). The design of the clock target restricts cylinder axis accuracy to the nearest 15 degrees . There was evidence of a learning effect for the focometer: the second and third measurements were more repeatable in the untrained group. There were no differences between the mean (1.03 +/- 2.28) and third focometer (-1.05 +/- 2.32) measurements (p = 0.34). However, using the third focometer measurement, 94% of participants had visual acuities of at least 6/12(-2). CONCLUSIONS: This study highlighted the focometer's restricted power range, inaccuracy of astigmatism and axis determination, and dependence on subject understanding and compliance. Therefore, in most clinical settings, the focometer would not be adequate for quantifying refractive error, but the focometer spherical equivalent was within acceptable limits of the autorefractor, and the visual acuity with lenses determined by the focometer indicates its potential usefulness in public health settings, especially where only spherical ready-made spectacles are dispensed. There may be more cost-effective ways to determine refractive error in these circumstances. A potentially important enhancement in focometer methodology that improves its ease of use was identified: use only the third measurement for each eye. 相似文献
7.
Sarah A. Taylor Jacqueline Benedetti David Schuller Stephen P. Richman Goronwy O. Broun Alexander Hantel 《Investigational new drugs》1993,11(2-3):227-229
Summary Twenty-two patients with recurrent or metastatic squamous cell carcinoma of the head and neck were treated with piroxantrone 150 mg/m2 intravenously every 21 days. There were no objective responses. The 95% upper confidence bound for response is 15%. Primary toxicity was hematologic. 相似文献
8.
9.
Clinical Efficacy of New Antiepileptic Drugs in Refractory Partial Epilepsy: Experience in the United States With Three Novel Drugs 总被引:1,自引:1,他引:0
Jacqueline A. French 《Epilepsia》1996,37(S2):S23-S26
Summary: A number of new antiepileptic drugs (AEDs), including topiramate (TPM), felbamate (FBM), and gabapentin (GBP), are approved or believed to be close to approval for marketing in the United States. Key efficacy findings for these AEDs in refractory partial epilepsy were reviewed. Large and significant drug-placebo differences were observed with TPM in two large dose-finding trials conducted in the United States. The minimal effective dose of TPM in the population studied was determined to be approximately 200 mg/day, and doses above 600 mg/day produced good efficacy but little incremental benefit versus the lower dosages for the overall study population. FBM is active in partial epilepsy, although seizure reduction is less marked and drug interactions complicate the findings. GBP is also active in this population, but only the 1,800 mg/day dosage was significantly better than placebo with respect to percent re-sponders. It may be useful to explore higher dosage ranges for both FBM and GBP if they can be well tolerated. 相似文献
10.
Synergistic antiproliferative activity of quercetin and cisplatin on ovarian cancer cell growth 总被引:1,自引:0,他引:1
G Scambia F O Ranelletti P Benedetti Panici G Bonanno R De Vincenzo M Piantelli S Mancuso 《Anti-cancer drugs》1990,1(1):45-48
It has been demonstrated that the flavonoid quercetin (3,3',4',5-7-pentahydroxyflavone) (Q) inhibits the growth of several cancer cell lines and that the antiproliferative activity of this substance is mediated by a so-called type II estrogen binding site (type II EBS). We investigated the effects of quercetin and cisplatin (CDDP) alone and in combination on the proliferation of the ovarian cancer cell line OVCA 433. Both drugs exhibited a dose-related growth inhibition in a range of concentrations between 0.01 and 2.5 microM and 0.01 and 2.5 micrograms/ml for Q and CDDP respectively. The combination of the two drugs resulted in a synergistic antiproliferative activity. Two other flavonoids tested, i.e., rutin (3-rhamnosylglucoside of quercetin) and hesperidin [7-b rutinoside of hesperetin (3'-5-3-hydroxy-4-methoxyflavone)] were ineffective both alone and in combination with CDDP. Since both rutin and hesperidin do not bind to type II EBS it can be hypothesized that Q synergizes with CDDP by acting through an interaction with these binding sites. 相似文献